NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

There is absolutely no indication that anything you just posted there is vaguely true. It is cutting edge, no doubt, and scaling it may involve efforts behind the scenes, but no one here knows exactly how far along they are or what it involves and there may in fact be no real delay at all, just a need to get the approval process going based on mostly, not all, but mostly current production tech. And slotting in Flaskworks, while it may be Sawston 2.0x that may not be that far out, and the validation may be much further along than anyone thinks, just not part of the current rollout. No one knows. And their job is not to tell everyone every competitive detail at every moment. If they have a supply issue, that is to be addressed as well, and there is no guarantee that a larger company would have a faster or better solution there either.

Anyone can throw up uninformed opinions. The secret is to know when one’s opinion is opinion only and probably more guess than not.